BioPharma Resources

Drug Trial Radar · NCT07753603

Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

A Phase 3, Randomized, Double-mask, Placebo-controlled Study With Open-label Extension to Evaluate the Efficacy and Safety of Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 130 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

130

Planned (sponsor's estimate)

Start

Aug 4, 2026

Primary completion

Jun 30, 2028

Study completion Jun 28, 2030

Sponsor

Lead sponsor
Sling Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Aug 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate the efficacy, safety, and tolerability of linsitinib in participants with moderate to severe Thyroid Eye Disease (TED).

Conditions

  • Thyroid Eye Disease, TED
  • Graves Orbitopathy

Interventions

  • linsitinibDrug

    150 mg linsitinib is taken twice daily by mouth for 24 weeks

  • PlaceboDrug

    0 mg placebo taken twice daily by mouth for 24 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Measure percentage of participants who are Proptosis Responders at Week 24Time frame: 24 weeks

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Sun City Clinical Research

    Glendale, Arizona · Recruiting

  • Thrive Health Research LLC

    Beverly Hills, California · Recruiting

  • Alliance Research Institute

    Canoga Park, California · Recruiting

  • Pasadena Clinical Trials

    Pasadena, California · Recruiting

  • Silkiss Eye Surgery

    San Francisco, California · Recruiting

  • Advancing Research International, LLC

    Santa Monica, California · Recruiting

  • Florida International Medical Research

    Coral Gables, Florida · Recruiting

  • Rovia Clinical Research at Florida Eye Specialists

    Jacksonville, Florida · Recruiting

  • Ophthalmic Consultants of Boston, Inc

    East Weymouth, Massachusetts · Recruiting

  • Kahana Oculoplastic & Orbital Surgery

    Livonia, Michigan · Recruiting

  • Advancing Research International

    Las Vegas, Nevada · Recruiting

  • Vector Clinical Trials

    Reno, Nevada · Recruiting

  • The Center for Eye and Facial Plastic Surgery

    Somerset, New Jersey · Recruiting

  • Columbia University Ophthalmology

    New York, New York · Not yet recruiting

  • Asheville Clinical Trials

    Asheville, North Carolina · Recruiting

  • Gulf Coast Clinical Trials

    Houston, Texas · Recruiting

  • Virginia Eye Consultants

    Norfolk, Virginia · Recruiting

  • WVU Eye Institute

    Morgantown, West Virginia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.